CELLUMED Co (XKRX:049180) FCF Margin % : 7.01% (As of Mar. 2024)

View and export this data going back to 2002. Start your Free Trial

What is CELLUMED Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. CELLUMED Co's Free Cash Flow for the three months ended in Mar. 2024 was ₩1,841 Mil. CELLUMED Co's Revenue for the three months ended in Mar. 2024 was ₩26,271 Mil. Therefore, CELLUMED Co's FCF Margin % for the quarter that ended in Mar. 2024 was 7.01%.

As of today, CELLUMED Co's current FCF Yield % is -13.13%.

The historical rank and industry rank for CELLUMED Co's FCF Margin % or its related term are showing as below:

XKRX:049180' s FCF Margin % Range Over the Past 10 Years
Min: -96.78 Med: -30.2 Max: -4.95
Current: -8.96

During the past 13 years, the highest FCF Margin % of CELLUMED Co was -4.95%. The lowest was -96.78%. And the median was -30.20%.

XKRX:049180's FCF Margin % is ranked worse than
52.17% of 830 companies
in the Medical Devices & Instruments industry
Industry Median: -7.11 vs XKRX:049180: -8.96

CELLUMED Co FCF Margin % Historical Data

The historical data trend for CELLUMED Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CELLUMED Co FCF Margin % Chart

CELLUMED Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-13.46

-5.70

-4.95

-11.50

-13.26

CELLUMED Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-8.49	-7.98	-25.48	-9.75	7.01

Competitive Comparison of CELLUMED Co's FCF Margin %

For the Medical Instruments & Supplies subindustry, CELLUMED Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CELLUMED Co's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CELLUMED Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where CELLUMED Co's FCF Margin % falls into.

CELLUMED Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

CELLUMED Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-12669.232	/	95552.96
	=	-13.26 %

CELLUMED Co's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	1841.148	/	26271.249
	=	7.01 %

CELLUMED Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of CELLUMED Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

CELLUMED Co (XKRX:049180) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CELLUMED Co Ltd (XKRX:049180) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Acetechno Tower 9 402, Gasan-dong, Geumcheon-gu, Seoul, KOR, 153-782

Website

http://www.cellumed.co.kr

CELLUMED Co Ltd is a Korean company which is engaged in manufacturing and sale of medical equipment and biosimilars. Its products portfolio includes allografts for tissue repair, bone sponges, bone powders and demineralized bone matrixes (DBMs) for bone regeneration and biosimilars such as bone morphogenetic protein 2 (BMP2) reagents and others. It also produces medical devices, such as spinal fixation systems, joint replacements, and navigation systems.

CELLUMED Co (XKRX:049180) Headlines

No Headlines